Rhenman & Partners Asset Management AB as of March 31, 2019
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 93 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| UnitedHealth (UNH) | 3.6 | $31M | 123k | 247.26 | |
| Jazz Pharmaceuticals (JAZZ) | 3.1 | $27M | 187k | 142.95 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.1 | $27M | 144k | 183.95 | |
| Abiomed | 3.1 | $26M | 93k | 285.59 | |
| Cigna Corp (CI) | 3.0 | $26M | 160k | 160.82 | |
| Horizon Pharma | 2.9 | $25M | 940k | 26.43 | |
| Nektar Therapeutics (NKTR) | 2.9 | $25M | 734k | 33.60 | |
| Livanova Plc Ord (LIVN) | 2.7 | $23M | 241k | 97.25 | |
| Novocure Ltd ord (NVCR) | 2.6 | $22M | 455k | 48.17 | |
| Anthem (ELV) | 2.5 | $21M | 74k | 286.98 | |
| Abbott Laboratories (ABT) | 2.4 | $21M | 260k | 79.94 | |
| BioMarin Pharmaceutical (BMRN) | 2.4 | $21M | 232k | 88.83 | |
| Humana (HUM) | 2.4 | $21M | 77k | 266.00 | |
| Esperion Therapeutics (ESPR) | 2.2 | $19M | 480k | 40.15 | |
| CVS Caremark Corporation (CVS) | 2.2 | $19M | 354k | 53.93 | |
| Becton, Dickinson and (BDX) | 2.2 | $19M | 75k | 249.73 | |
| Alexion Pharmaceuticals | 2.2 | $18M | 137k | 135.18 | |
| Glaukos (GKOS) | 2.2 | $19M | 236k | 78.37 | |
| Macrogenics (MGNX) | 2.0 | $17M | 967k | 17.98 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $16M | 177k | 88.10 | |
| Medtronic (MDT) | 1.8 | $15M | 169k | 91.08 | |
| Array BioPharma | 1.7 | $15M | 607k | 24.38 | |
| Boston Scientific Corporation (BSX) | 1.6 | $14M | 368k | 38.38 | |
| Allergan | 1.5 | $13M | 89k | 146.41 | |
| Eli Lilly & Co. (LLY) | 1.5 | $13M | 99k | 129.76 | |
| Aerie Pharmaceuticals | 1.4 | $12M | 260k | 47.50 | |
| Immunomedics | 1.4 | $12M | 616k | 19.21 | |
| Myokardia | 1.4 | $12M | 225k | 51.99 | |
| Intra Cellular Therapies (ITCI) | 1.4 | $12M | 950k | 12.18 | |
| Seattle Genetics | 1.3 | $11M | 151k | 73.24 | |
| Bristol Myers Squibb (BMY) | 1.3 | $11M | 230k | 47.71 | |
| Centene Corporation (CNC) | 1.2 | $11M | 200k | 53.10 | |
| Arena Pharmaceuticals | 1.2 | $11M | 235k | 44.83 | |
| Exelixis (EXEL) | 1.2 | $10M | 430k | 23.80 | |
| Fibrogen (FGEN) | 1.2 | $10M | 190k | 54.35 | |
| Xencor (XNCR) | 1.2 | $10M | 326k | 31.06 | |
| Mirati Therapeutics | 1.1 | $9.3M | 127k | 73.30 | |
| AmerisourceBergen (COR) | 1.1 | $9.3M | 117k | 79.52 | |
| Walgreen Boots Alliance (WBA) | 1.1 | $9.2M | 145k | 63.27 | |
| Incyte Corporation (INCY) | 1.0 | $8.6M | 100k | 86.01 | |
| EXACT Sciences Corporation (EXAS) | 1.0 | $8.7M | 100k | 86.62 | |
| Bluebird Bio (BLUE) | 1.0 | $8.7M | 55k | 157.33 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $8.6M | 92k | 93.45 | |
| Agios Pharmaceuticals (AGIO) | 1.0 | $8.6M | 127k | 67.44 | |
| Iovance Biotherapeutics (IOVA) | 1.0 | $8.4M | 880k | 9.51 | |
| Thermo Fisher Scientific (TMO) | 1.0 | $8.2M | 30k | 273.73 | |
| Sage Therapeutics (SAGE) | 1.0 | $8.2M | 52k | 159.05 | |
| Omnicell (OMCL) | 0.9 | $8.1M | 100k | 80.84 | |
| Sangamo Biosciences (SGMO) | 0.9 | $8.1M | 844k | 9.54 | |
| Amarin Corporation (AMRN) | 0.9 | $7.7M | 371k | 20.76 | |
| Diplomat Pharmacy | 0.8 | $7.0M | 1.2M | 5.81 | |
| Dermira | 0.8 | $6.8M | 500k | 13.55 | |
| Regeneron Pharmaceuticals (REGN) | 0.8 | $6.6M | 16k | 410.62 | |
| Celgene Corporation | 0.7 | $6.2M | 66k | 94.34 | |
| Coherus Biosciences (CHRS) | 0.7 | $6.2M | 451k | 13.64 | |
| Rigel Pharmaceuticals (RIGL) | 0.7 | $5.8M | 2.3M | 2.57 | |
| Edwards Lifesciences (EW) | 0.6 | $5.1M | 27k | 191.35 | |
| Abbvie (ABBV) | 0.6 | $4.8M | 60k | 80.58 | |
| Viewray (VRAYQ) | 0.6 | $4.9M | 664k | 7.39 | |
| Abeona Therapeutics | 0.6 | $4.8M | 649k | 7.36 | |
| Alkermes (ALKS) | 0.5 | $4.4M | 120k | 36.49 | |
| Medicines Company | 0.4 | $3.6M | 130k | 27.95 | |
| G1 Therapeutics (GTHX) | 0.4 | $3.5M | 212k | 16.60 | |
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $3.4M | 27k | 125.25 | |
| Aimmune Therapeutics | 0.4 | $3.3M | 149k | 22.35 | |
| Ra Pharmaceuticals | 0.4 | $3.4M | 150k | 22.40 | |
| Acceleron Pharma | 0.4 | $3.3M | 70k | 46.57 | |
| Revance Therapeutics (RVNC) | 0.4 | $3.0M | 193k | 15.76 | |
| Nanostring Technologies (NSTGQ) | 0.3 | $2.9M | 120k | 23.93 | |
| Qiagen Nv | 0.3 | $2.4M | 60k | 40.58 | |
| Dynavax Technologies (DVAX) | 0.2 | $2.1M | 285k | 7.31 | |
| Flexion Therapeutics | 0.2 | $1.5M | 117k | 12.48 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $1.0M | 300k | 3.35 | |
| Achillion Pharmaceuticals | 0.1 | $822k | 278k | 2.96 | |
| Epizyme | 0.1 | $734k | 59k | 12.40 | |
| Adverum Biotechnologies | 0.1 | $627k | 120k | 5.24 | |
| Exxon Mobil Corporation (XOM) | 0.1 | $494k | 6.1k | 80.84 | |
| Walt Disney Company (DIS) | 0.1 | $387k | 3.5k | 111.11 | |
| Chevron Corporation (CVX) | 0.1 | $460k | 3.7k | 123.23 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $457k | 377k | 1.21 | |
| Microsoft Corporation (MSFT) | 0.0 | $340k | 2.9k | 117.77 | |
| International Business Machines (IBM) | 0.0 | $347k | 2.5k | 141.00 | |
| Qualcomm (QCOM) | 0.0 | $369k | 6.5k | 56.98 | |
| Anheuser-Busch InBev NV (BUD) | 0.0 | $318k | 3.8k | 83.95 | |
| JPMorgan Chase & Co. (JPM) | 0.0 | $278k | 2.7k | 101.20 | |
| Wells Fargo & Company (WFC) | 0.0 | $283k | 5.9k | 48.31 | |
| Halliburton Company (HAL) | 0.0 | $270k | 9.2k | 29.28 | |
| Symantec Corporation | 0.0 | $224k | 9.7k | 23.01 | |
| Ford Motor Company (F) | 0.0 | $285k | 32k | 8.79 | |
| Janus Henderson Group Plc Ord (JHG) | 0.0 | $295k | 12k | 24.94 | |
| Pfizer (PFE) | 0.0 | $213k | 5.0k | 42.52 | |
| Chimerix (CMRX) | 0.0 | $145k | 69k | 2.11 | |
| Alphabet Inc Class A cs (GOOGL) | 0.0 | $209k | 178.00 | 1174.16 |
